An effective treatment of human diseases using regenerative medicine and cell therapy approaches requires a large number of cells. Cultivation of cells on microcarriers is a promising approach due to the high surface‐to‐volume ratios that these microcarriers offer. Here, multifunctional temperature‐responsive microcarriers (cytoGel) made of an interpenetrating hydrogel network composed of poly(N‐isopropylacrylamide) (PNIPAM), poly(ethylene glycol) diacrylate (PEGDA), and gelatin methacryloyl (GelMA) are developed. A flow‐focusing microfluidic chip is used to produce microcarriers with diameters in the range of 100–300 μm and uniform size distribution (polydispersity index of ≈0.08). The mechanical properties and cells adhesion properties of cytoGel are adjusted by changing the composition hydrogel composition. Notably, GelMA regulates the temperature response and enhances microcarrier stiffness. Human‐derived glioma cells (U87) are grown on cytoGel in static and dynamic culture conditions with cell viabilities greater than 90%. Enzyme‐free cell detachment is achieved at room temperature with up to 70% detachment efficiency. Controlled release of bioactive molecules from cytoGel is accomplished for over a week to showcase the potential use of microcarriers for localized delivery of growth factors to cell surfaces. These microcarriers hold great promise for the efficient expansion of cells for the industrial‐scale culture of therapeutic cells.

No abstract

Author affiliations and support information (if applicable) appear at the end of this article.

Temperature and humidity measurements in electrochemical energy devices are essential for maximizing their overall performance under different operating conditions and avoiding hazardous consequences that may arise from the malfunction of these systems. Using sensors for in situ measurements of temperature and relative humidity (RH) is a promising approach for continuous monitoring and management of electrochemical power sources. Here, we report on the feasibility of using thread-based sensors for in situ measurements of temperature and RH in proton exchange membrane fuel cells (PEMFCs) as an example of electrochemical energy devices. Commodity threads are low-cost and flexible materials that hold great promise for the creation of complex three-dimensional (3D) circuits using well-established textile methods such as weaving, braiding, and embroidering. Ex situ and in situ characterization show that threads can be introduced in the gas diffusion layer (GDL) structure to inscribe water highways within the GDL with minimal impact on the GDL microstructure and transport properties. Fluorinated ethylene propylene (FEP) is coated on thread-based sensors to decouple the response to temperature and humidity; the resulting threads achieve a linear change of resistance with temperature (−0.31%/°C), while RH is monitored with a second thread coated with poly(dimethylsiloxane) (PDMS). The combination of both threads allows for minimally invasive and dynamically responsive monitoring of local temperature and RH within the electrode of PEMFCs.

Viral-associated respiratory infectious diseases are one of the most prominent subsets of respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an infection caused by viruses infecting the respiratory system. For the past 100 years, viral associated respiratory epidemics have been the most common cause of infectious disease worldwide. Due to several drawbacks of the current anti-viral treatments, such as drug resistance generation and non-targeting of viral proteins, the development of novel nanotherapeutic or nano-vaccine strategies can be considered essential. Due to their specific physical and biological properties, nanoparticles hold promising opportunities for both anti-viral treatments and vaccines against viral infections. Besides the specific physiological properties of the respiratory system, there is a significant demand for utilizing nano-designs in the production of vaccines or antiviral agents for airway-localized administration. SARS-CoV-2, as an immediate example of respiratory viruses, is an enveloped, positive-sense, single-stranded RNA virus belonging to the coronaviridae family. COVID-19 can lead to acute respiratory distress syndrome, similarly to other members of the coronaviridae. Hence, reviewing the current and past emerging nanotechnology-based medications on similar respiratory viral diseases can identify pathways towards generating novel SARS-CoV-2 nanotherapeutics and/or nano-vaccines.